Insider Transactions Reported by 8 Insiders of IGC Pharma, Inc.

Symbol: IGC on NYSE
Location: Potomac, MD

Quick Takeaways

IGC - IGC Pharma, Inc. has 8 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 07 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

IGC Pharma, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)	10%+ Owner	$4,700,000	Mixed	22 Mar 2024
Ram Mukunda	CEO, Director	$1,564,538	Mixed	01 Apr 2026
Richard K. Prins	Director	$433,708	Mixed	01 Apr 2026
Claudia Grimaldi	PFO, Director	$386,281	Mixed	01 Apr 2026
James P. Moran	Director	$347,735	Mixed	01 Apr 2026
Rohit Goel	Senior Director of Finance&PAO	$79,900	Mixed	13 May 2021
John E. Lynch	Director	$45,696	Mixed	31 May 2022
Terry L. Lierman	Director		Mixed	17 Oct 2025

Top shareholders of IGC Pharma, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)	3/4/5	10%+ Owner	— class O/S missing	13,823,529	$4,700,000	—	22 Mar 2024	3/4/5
Ram Mukunda	3/4/5	CEO, Director	— mixed-class rows	6,270,098 mixed-class rows	$1,564,538	—	01 Apr 2026	3/4/5
Richard K. Prins	3/4/5	Director	— mixed-class rows	2,361,251 mixed-class rows	$433,708	—	01 Apr 2026	3/4/5
Claudia Grimaldi	3/4/5	PFO, Director	— mixed-class rows	1,594,252 mixed-class rows	$386,281	—	01 Apr 2026	3/4/5
James P. Moran	3/4/5	Director	— mixed-class rows	1,785,735 mixed-class rows	$347,735	—	01 Apr 2026	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	1,149,268	$322,945	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	919,641	$258,787	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	860,477	$242,169	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	— class O/S missing	703,798	$198,049	—	31 Dec 2025	13F
Rohit Goel	3/4/5	Senior Director of Finance&PAO	— class O/S missing	235,000	$79,900	—	13 May 2021	3/4/5
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	277,594	$78,115	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	— class O/S missing	200,799	$56,505	—	31 Dec 2025	13F
John E. Lynch	3/4/5	Director	— mixed-class rows	396,901 mixed-class rows	$45,696	—	31 May 2022	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	154,959	$43,605	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	113,407	$31,913	—	31 Dec 2025	13F
DEARBORN PARTNERS LLC	13F	Company	— class O/S missing	84,401	$23,750	—	31 Dec 2025	13F
LAWOOD & CO	13F	Company	— class O/S missing	75,000	$21,105	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	65,541	$18,443	—	31 Dec 2025	13F
Fisher Asset Management, LLC	13F	Company	— class O/S missing	43,400	$12,212	—	31 Dec 2025	13F
TRUIST FINANCIAL CORP	13F	Company	— class O/S missing	36,667	$10,318	—	31 Dec 2025	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	— class O/S missing	33,348	$9,380	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	— class O/S missing	28,324	$7,970	—	31 Dec 2025	13F
T3 Companies, LLC	13F	Company	— class O/S missing	20,000	$5,628	—	31 Dec 2025	13F
UBS Group AG	13F	Company	— class O/S missing	19,869	$5,583	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	— class O/S missing	17,707	$4,983	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	14,392	$4,050	—	31 Dec 2025	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	7,187	$2,022	—	31 Dec 2025	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	3,000	$840	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	1,808	$508	—	31 Dec 2025	13F
CIBC Private Wealth Group LLC	13F	Company	— class O/S missing	655	$184	—	31 Dec 2025	13F
Caitlin John, LLC	13F	Company	— class O/S missing	200	$56	—	31 Dec 2025	13F
JONES FINANCIAL COMPANIES LLLP	13F	Company	— class O/S missing	110	$31	—	31 Dec 2025	13F
Farther Finance Advisors, LLC	13F	Company	— class O/S missing	100	$28	—	31 Dec 2025	13F
Hurley Capital, LLC	13F	Company	— class O/S missing	100	$28	—	31 Dec 2025	13F
Root Financial Partners, LLC	13F	Company	— class O/S missing	100	$28	—	31 Dec 2025	13F
DHJJ Financial Advisors, Ltd.	13F	Company	— class O/S missing	80	$23	—	31 Dec 2025	13F
Triumph Capital Management	13F	Company	— class O/S missing	2	$1	—	31 Dec 2025	13F
Terry L. Lierman	3/4/5	Director	— class O/S missing	500,000	—	—	17 Oct 2025	3/4/5

Recent Insider Transactions by Companies or Individuals for IGC Pharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Richard K. Prins	IGC	Common Stock	Options Exercise	12.4%	170,000	1,541,251	01 Apr 2026	Direct
Richard K. Prins	IGC	Restricted Stock Units	Options Exercise	-100%	-170,000	0	01 Apr 2026	Direct
Ram Mukunda	IGC	Common Stock	Options Exercise	5.81%	49,999	910,751	01 Apr 2026	BY SPOUSE
Ram Mukunda	IGC	Common Stock	Options Exercise	16.4%	656,410	4,649,088	01 Apr 2026	Direct
Ram Mukunda	IGC	Restricted Stock Units	Options Exercise	-100%	-49,999	0	01 Apr 2026	BY SPOUSE
Ram Mukunda	IGC	Options	Options Exercise	-32.3%	-323,077	676,925	01 Apr 2026	Direct
Ram Mukunda	IGC	Restricted Stock Units	Options Exercise	-100%	-333,333	0	01 Apr 2026	Direct
James P. Moran	IGC	Common Stock	Options Exercise	11.8%	130,000	1,235,735	01 Apr 2026	Direct
James P. Moran	IGC	Restricted Stock Units	Options Exercise	-100%	-130,000	0	01 Apr 2026	Direct
Claudia Grimaldi	IGC	Common Stock	Options Exercise	21%	238,462	1,372,714	01 Apr 2026	Direct
Claudia Grimaldi	IGC	Options	Options Exercise	-38.5%	-138,462	221,538	01 Apr 2026	Direct
Claudia Grimaldi	IGC	Restricted Stock Units	Options Exercise	-100%	-100,000	0	01 Apr 2026	Direct
Ram Mukunda	IGC	Common Stock	Options Exercise	6.17%	50,000	860,752	03 Feb 2026	BY SPOUSE
Ram Mukunda	IGC	Restricted Stock Units	Award		83,333	66,666	03 Feb 2026	BY SPOUSE
Richard K. Prins	IGC	Common Stock	Options Exercise	7.87%	100,000	1,371,251	19 Jan 2026	Direct
Richard K. Prins	IGC	Restricted Stock Units	Options Exercise	-66.7%	-100,000	50,000	19 Jan 2026	Direct
Richard K. Prins	IGC	Options	Award		750,000	750,000	17 Oct 2025	Direct
James P. Moran	IGC	Options	Award		500,000	500,000	17 Oct 2025	Direct
Terry L. Lierman	IGC	Options	Award		500,000	500,000	17 Oct 2025	Direct
Claudia Grimaldi	IGC	Common Stock	Gift	-4.22%	-50,000	1,134,252	17 Oct 2025	Direct
Claudia Grimaldi	IGC	Options	Award		1,500,000	1,000,000	17 Oct 2025	Direct
Ram Mukunda	IGC	Common Stock	Gift	-2.44%	-100,000	3,992,678	17 Oct 2025	Direct
Ram Mukunda	IGC	Options	Award		4,500,000	3,000,000	17 Oct 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.